Since 2022, multi-claimant litigation in England has significantly increased, particularly Competition Appeal Tribunal (“CAT”) filings and Group Litigation Orders (“GLOs”). Multi-billion-dollar cases are increasingly being...more
2/21/2025
/ Antitrust Provisions ,
Appeals ,
Class Action ,
Collective Actions ,
Competition ,
Corporate Counsel ,
Environmental Social & Governance (ESG) ,
Evidence ,
Litigation Strategies ,
Settlement ,
UK
Uber Drives Dual MDL Challenges to Ninth Circuit -
Key Takeaways -
Ninth Circuit review of Uber’s non-consolidation clauses in an MDL context could generate new precedent on the enforceability of similar clauses and shape...more
11/1/2024
/ Amended Complaints ,
Jurisdiction ,
Litigation Funding ,
Litigation Strategies ,
Multidistrict Litigation ,
Popular ,
Public Safety ,
Royal Canin USA Inc v Wullschleger ,
SCOTUS ,
Sexual Assault ,
Terms of Use ,
Third-Party ,
Tort ,
Uber
Recent court decisions have signaled the English courts’ willingness to embrace multi-claimant litigation and to broaden the types of questions decided on a collective basis. These developments have led UK-based plaintiffs’...more
Addressing an important issue for in-house counsel, the Supreme Court will resolve a three-way circuit split as to when “dual-purpose” attorney-client communications that contain both legal and non-legal advice are protected...more
In June of this year, FDA announced a proposed rule that would permit approval for nonprescription drug products with an Additional Condition for Nonprescription Use—a category of nonprescription drugs where FDA determines...more
10/19/2022
/ Abbreviated New Drug Application (ANDA) ,
Adverse Events ,
Draft Guidance ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Healthcare Workers ,
Labeling ,
Manufacturers ,
Over The Counter Drugs (OTC) ,
Prescription Drugs ,
Proposed Rules ,
Reporting Requirements ,
Retailers ,
Strict Product Liability
Key Takeaways - The FDA’s Patient Engagement Advisory Committee, organized under the Center for Devices and Radiological Health (“CDRH”), held a public meeting on October 6, 2021, to discuss issues surrounding the...more